Helicobacter pylori: What schemes of eradication are essential today?

Terapevticheskii Arkhiv

Volumn 83, Issue 8, 2011, Pages 41-44

  Maev, I V ^a   Samsonov, A A ^a   Golubev, N N ^a  

^a A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

Author keywords

Antihelicobacter therapy; Bismuth; Resistance to antibiotics; Review; Successive therapy

Indexed keywords

ANTIINFECTIVE AGENT; BISMUTH CITRATE; METRONIDAZOLE; ORGANOMETALLIC COMPOUND; PROTON PUMP INHIBITOR;

ARTICLE; DRUG COMBINATION; DRUG EFFECT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; ORGANOMETALLIC COMPOUNDS; PROTON PUMP INHIBITORS; TREATMENT OUTCOME;

EID: 80053500164     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Warren J. R., Marshall B. J. Unidentified curved bacilli on gastric epithelium in active chronic Gastritis. Lancet 1983; 1: 1273-1275.
2. Malfertheiner P., Megraud F., O 'Morain C. et al. Current concepts in the management of Helicobacter pylori infection - The Maastricht III Consensus Report. Gut 2007; 56: 772-781. (Pubitemid 46854190)
3. Chey W. D., Wong B. C. Y. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol. 2007; 102: 1808-1825. (Pubitemid 47206706)
4. Asaka M., Kato M., Takahashi S. et al. Guidelines for the management of helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010; 15: 1-20.
5. Malfertheiner P. Bismuth improves PPI-based triple therapy for H. pylori eradication. Nat. Rev. Gastroenterol. Hepatol. 2010; 7: 538-539.
6. Graham D. Y., Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010; 59: 1143-1153.
7. Malfertheiner P., Megraud F. Quadruple therapy with bismuth subcitrate potassium, metronidazole, tetracycline, and omeprazole is superior to triple therapy with omeprazole, amoxicillin, and clarithromycin in the eradication of helicobacter pylori. Gastroenterology 2010; 138 (Suppl. 1): S-33.
8. De Francesco V., Margiotta M., Zullo A. et al. Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy. J. Antimicrob. Chemother. 2007; 59: 783-785. (Pubitemid 47073419)
9. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-1384.
10. Fischbach L., Evans E. L. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment. Pharmacol. Ther. 2007; 26: 343-357. (Pubitemid 47063149)
11. Treiber G., Ammon S., Malfertheiner P., Klotz U. Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures. Helicobacter 2002; 7: 225-231.
12. Fischbach L. A., van Zanten S., Dickason J. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment. Pharmacol. Ther. 2004; 20: 1071-1082. (Pubitemid 39657940)
13. Sun Q., Liang X., Zheng Q. et al. High efficacy of 14-Day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication. Helicobacter 2010; 15: 233-238.
14. Vaira D., Zullo A., Vakil N. et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann. Intern. Med. 2007; 146: 556-563. (Pubitemid 351650536)
15. Jafri N. S., Homung C. A., Howden C. W. Meta-analysis: Sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann. Intern. Med. 2008; 148: 923-931. (Pubitemid 351860824)
16. Vakil N., Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology 2007; 133: 985-1001. (Pubitemid 47374146)
17. Gisbert J. P., Gisbert J. L., Marcos S. et al. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two, Helicobacter pylori treatment failures. Aliment Pharmacol. Ther, 2006; 24: 1469-1474. (Pubitemid 44657124)
18. Giannini E. G., Bilardi C, Dulbecco P. et al. A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 2006; 23: 281-287. (Pubitemid 43382038)
19. Cammarota G, Martino A., Pirozzi G. et al. High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2004; 19: 789-795. (Pubitemid 38496645)